173 related articles for article (PubMed ID: 21391903)
1. Pharmaceutical reactivation of p53 pathways in cancer.
Azmi AS
Curr Pharm Des; 2011; 17(6):534-5. PubMed ID: 21391903
[No Abstract] [Full Text] [Related]
2. Fortifying p53 - beyond Mdm2 inhibitors.
Sriraman A; Li Y; Dobbelstein M
Aging (Albany NY); 2016 Sep; 8(9):1836-1837. PubMed ID: 27688014
[No Abstract] [Full Text] [Related]
3. Peptide activators of the p53 tumor suppressor.
Zhan C; Lu W
Curr Pharm Des; 2011; 17(6):603-9. PubMed ID: 21391910
[TBL] [Abstract][Full Text] [Related]
4. Reactivation of p53 gene by MDM2 inhibitors: A novel therapy for cancer treatment.
Gupta A; Shah K; Oza MJ; Behl T
Biomed Pharmacother; 2019 Jan; 109():484-492. PubMed ID: 30551517
[TBL] [Abstract][Full Text] [Related]
5. MDM2 oligomers: antagonizers of the guardian of the genome.
Leslie PL; Zhang Y
Oncogene; 2016 Dec; 35(48):6157-6165. PubMed ID: 27041565
[TBL] [Abstract][Full Text] [Related]
6. The role of p53 in cancer drug resistance and targeted chemotherapy.
Hientz K; Mohr A; Bhakta-Guha D; Efferth T
Oncotarget; 2017 Jan; 8(5):8921-8946. PubMed ID: 27888811
[TBL] [Abstract][Full Text] [Related]
7. Reactivation of p53 by inhibiting Mdm2 E3 ligase: a novel antitumor approach.
Di J; Zhang Y; Zheng J
Curr Cancer Drug Targets; 2011 Oct; 11(8):987-94. PubMed ID: 21762075
[TBL] [Abstract][Full Text] [Related]
8. Patented inhibitors of p53-Mdm2 interaction (2006 - 2008).
Weber L
Expert Opin Ther Pat; 2010 Feb; 20(2):179-91. PubMed ID: 20100001
[TBL] [Abstract][Full Text] [Related]
9. Resistance acquisition to MDM2 inhibitors.
Cinatl J; Speidel D; Hardcastle I; Michaelis M
Biochem Soc Trans; 2014 Aug; 42(4):752-7. PubMed ID: 25109953
[TBL] [Abstract][Full Text] [Related]
10. Oncology. Recruiting the cell's own guardian for cancer therapy.
Marx J
Science; 2007 Mar; 315(5816):1211-3. PubMed ID: 17332387
[No Abstract] [Full Text] [Related]
11. Small-molecule inhibitors of p53-MDM2 interaction: the 2006-2010 update.
Millard M; Pathania D; Grande F; Xu S; Neamati N
Curr Pharm Des; 2011; 17(6):536-59. PubMed ID: 21391905
[TBL] [Abstract][Full Text] [Related]
12. Resistance mechanisms to inhibitors of p53-MDM2 interactions in cancer therapy: can we overcome them?
Haronikova L; Bonczek O; Zatloukalova P; Kokas-Zavadil F; Kucerikova M; Coates PJ; Fahraeus R; Vojtesek B
Cell Mol Biol Lett; 2021 Dec; 26(1):53. PubMed ID: 34911439
[TBL] [Abstract][Full Text] [Related]
13. Small molecule agents targeting the p53-MDM2 pathway for cancer therapy.
Wang W; Hu Y
Med Res Rev; 2012 Nov; 32(6):1159-96. PubMed ID: 23059763
[TBL] [Abstract][Full Text] [Related]
14. Network perspectives on HDM2 inhibitor chemotherapy combinations.
Azmi AS; Beck FW; Sarkar FH; Mohammad RM
Curr Pharm Des; 2011; 17(6):640-52. PubMed ID: 21391913
[TBL] [Abstract][Full Text] [Related]
15. MDM2 and MDM4: p53 regulators as targets in anticancer therapy.
Toledo F; Wahl GM
Int J Biochem Cell Biol; 2007; 39(7-8):1476-82. PubMed ID: 17499002
[TBL] [Abstract][Full Text] [Related]
16. [Role of p53 in leukemia].
Kojima K
Rinsho Ketsueki; 2014 Oct; 55(10):1724-30. PubMed ID: 25297733
[No Abstract] [Full Text] [Related]
17. Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy.
Tovar C; Rosinski J; Filipovic Z; Higgins B; Kolinsky K; Hilton H; Zhao X; Vu BT; Qing W; Packman K; Myklebost O; Heimbrook DC; Vassilev LT
Proc Natl Acad Sci U S A; 2006 Feb; 103(6):1888-93. PubMed ID: 16443686
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological reactivation of p53 as a strategy to treat cancer.
Zawacka-Pankau J; Selivanova G
J Intern Med; 2015 Feb; 277(2):248-259. PubMed ID: 25495071
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in validating MDM2 as a cancer target.
Rayburn ER; Ezell SJ; Zhang R
Anticancer Agents Med Chem; 2009 Oct; 9(8):882-903. PubMed ID: 19538162
[TBL] [Abstract][Full Text] [Related]
20. The regulation of MDM2 by multisite phosphorylation--opportunities for molecular-based intervention to target tumours?
Meek DW; Hupp TR
Semin Cancer Biol; 2010 Feb; 20(1):19-28. PubMed ID: 19897041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
